Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies
α-辅肌动蛋白:抗 DNA 抗体的肾致病性
基本信息
- 批准号:6903611
- 负责人:
- 金额:$ 28.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-12 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:DNAalpha actininantigen antibody reactionantinuclear autoantibodyclinical researchcytokineenzyme linked immunosorbent assayflow cytometrygender differencegene expressiongene targetinggenetic regulationgenetically modified animalshuman subjectimmunoprecipitationkidney celllaboratory mouselupus nephritismonoclonal antibodypathologic processpatient oriented researchprotein structurewestern blottings
项目摘要
DESCRIPTION (provided by applicant): Antibodies against double stranded (ds)
DNA are a characteristic serologic hallmark of SLE. While it has been
demonstrated that anti-dsDNA antibodies play a critical role in the
pathogenesis of lupus nephritis, the mechanisms of injury are incompletely
understood. Experimental evidence strongly suggests that at least some
anti-dsDNA antibodies are pathogenic by virtue of their direct cross-reactivity
with renal antigen. We recently demonstrated that a pathogenic anti-dsDNA
antibody (R4A) binds to a 100 kD protein expressed on the cell surface of a
mesangial cell line derived from a lupus-prone MRL-lpr/lpr mouse, and that
DNAse treatment of the lysate does not affect binding. Binding was greatly
diminished in lysates of a mesangial cell line derived from a non-autoimmune
mouse, suggesting that antigen expression and/or availability at the level of
the target organ may be a factor in determining susceptibility to lupus
nephritis. Following identification of the 100 kD protein bound by R4A as
alpha-actinin, the binding of R4A to alpha-actinin was confirmed by Western
blot, ELISA, and inhibition studies. High titers of anti-alpha-actinin
antibodies were found in the serum and kidney eluates of lupus mice with
nephritis, and in the serum of lupus patients.
The goals of this proposal are to study if cross-reactivity with alpha-actinin
may be an important determinant of the renal pathogenicity of some anti-DNA
antibodies, and if the expression of alpha-actinin is genetically regulated and
modulated by gender and exposure to cytokines. We will determine if
anti-alpha-actinin antibodies are pathogenic and if they cross-react with
dsDNA, by immunization of mice with alpha-actinin and studying the
anti-alpha-actinin antibody response in normal and autoimmune mice. The
molecular basis for the differential levels of antigen display of alpha-actinin
between autoimmune and non-autoimmune mouse strains will be studied, and the
effects of age, gender, and cytokines known to be present in lupus kidneys on
alpha-actinin expression and antibody binding will be determined. Finally, we
will identify the epitopes of alpha-actinin that are recognized by pathogenic
anti-dsDNA antibodies to understand the generation of anti-alpha-actinin
antibodies, and determine the potential of alpha-actinin peptides in the
treatment of acute lupus nephritis.
描述(由申请方提供):抗双链(ds)抗体
DNA是SLE的血清学标志。虽然已经
证明抗dsDNA抗体在细胞凋亡中起关键作用。
狼疮性肾炎的发病机制,损伤的机制是不完全的
明白实验证据有力地表明,至少有一些
抗dsDNA抗体由于它们的直接交叉反应性而具有致病性
肾抗原我们最近证明了一种致病性抗dsDNA抗体
抗体(R4 A)结合至表达于细胞表面上的100 kD蛋白质,
系膜细胞系来源于狼疮倾向的MRL-lpr/lpr小鼠,
裂解物的DNA酶处理不影响结合。绑定大大
在来源于非自身免疫性肾小球疾病的系膜细胞系的裂解物中减少,
小鼠,这表明抗原表达和/或可用性在小鼠的水平,
靶器官可能是决定狼疮易感性的一个因素
肾炎将R4 A结合的100 kD蛋白鉴定为
在α-辅肌动蛋白中,R4 A与α-辅肌动蛋白的结合被Western印迹证实。
印迹、ELISA和抑制研究。高滴度抗α辅肌动蛋白
在狼疮小鼠的血清和肾脏洗脱液中发现了抗体,
肾炎和狼疮患者的血清中。
本提案的目的是研究是否与α-辅肌动蛋白交叉反应
可能是某些抗DNA抗体肾脏致病性的重要决定因素
抗体,如果α-辅肌动蛋白的表达是遗传调节的,
受性别和暴露于细胞因子的调节。我们将确定是否
抗α辅肌动蛋白抗体是致病性的,如果它们与
dsDNA,通过用α-辅肌动蛋白免疫小鼠,并研究
正常和自身免疫小鼠中的抗α-辅肌动蛋白抗体应答。的
α-辅肌动蛋白抗原展示水平差异的分子基础
将研究自身免疫和非自身免疫小鼠品系之间的差异,
年龄、性别和已知存在于狼疮肾中的细胞因子对
将测定α-辅肌动蛋白表达和抗体结合。最后我们
将确定α-辅肌动蛋白的表位,
抗双链DNA抗体,以了解抗α辅肌动蛋白的产生
抗体,并确定潜在的α-辅肌动蛋白肽在
狼疮性肾炎的治疗方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHAIM PUTTERMAN其他文献
CHAIM PUTTERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHAIM PUTTERMAN', 18)}}的其他基金
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric
TWEAK 和 Fn14 在神经精神疾病发病机制和治疗中的作用
- 批准号:
8759704 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric
TWEAK 和 Fn14 在神经精神疾病发病机制和治疗中的作用
- 批准号:
9235665 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric
TWEAK 和 Fn14 在神经精神疾病发病机制和治疗中的作用
- 批准号:
8911775 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
The role of TWEAK and Fn14 in the Pathogenesis and Treatment of Neuropsychiatric
TWEAK 和 Fn14 在神经精神疾病发病机制和治疗中的作用
- 批准号:
9132170 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
TNF-like weak inducer of apoptosis (TWEAK) signaling: a novel therapeutic target
TNF 样弱凋亡诱导剂 (TWEAK) 信号传导:一种新的治疗靶点
- 批准号:
8183923 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis
狼疮性肾炎中的 TNF 样弱凋亡诱导剂 (TWEAK) 信号传导
- 批准号:
8715775 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis
狼疮性肾炎中的 TNF 样弱凋亡诱导剂 (TWEAK) 信号传导
- 批准号:
8322788 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
TNF-like weak inducer of apoptosis (TWEAK) signaling in lupus nephritis
狼疮性肾炎中的 TNF 样弱凋亡诱导剂 (TWEAK) 信号传导
- 批准号:
8540418 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
The Renal Pathogenicity of anti-DNA Antibodies
抗 DNA 抗体的肾脏致病性
- 批准号:
8290063 - 财政年份:2002
- 资助金额:
$ 28.89万 - 项目类别:
Alpha-Actinin:Renal Pathogenicity of anti-DNA Antibodies
α-辅肌动蛋白:抗 DNA 抗体的肾致病性
- 批准号:
7106615 - 财政年份:2002
- 资助金额:
$ 28.89万 - 项目类别:
相似国自然基金
Ca2+-CaM信号系统与丝状真菌中人辅肌动蛋白alpha-actinin同源基因对极性生长调控的分子机理
- 批准号:30770031
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Understanding the role of alpha-actinin in cardiac disease: from molecules to mice
了解 α-肌动蛋白在心脏病中的作用:从分子到小鼠
- 批准号:
2734442 - 财政年份:2022
- 资助金额:
$ 28.89万 - 项目类别:
Studentship
Alpha-actinin-4 as an oncogenic driver and therapeutic target in melanoma
Alpha-actinin-4 作为黑色素瘤的致癌驱动因素和治疗靶点
- 批准号:
nhmrc : GNT1099947 - 财政年份:2016
- 资助金额:
$ 28.89万 - 项目类别:
Project Grants
Alpha-actinin-4 as an oncogenic driver and therapeutic target in melanoma
Alpha-actinin-4 作为黑色素瘤的致癌驱动因素和治疗靶点
- 批准号:
nhmrc : 1099947 - 财政年份:2016
- 资助金额:
$ 28.89万 - 项目类别:
Project Grants
Production of full length alpha-actinin-3 protein from ACTN3 gene X genotype
从 ACTN3 基因 X 基因型生产全长 α-actinin-3 蛋白
- 批准号:
16K13015 - 财政年份:2016
- 资助金额:
$ 28.89万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Discovering The Effect of alpha-actinin-3 Deficiency on Muscle Adaptations to Exercise Training in Humans
发现 α-actinin-3 缺乏对人类运动训练肌肉适应的影响
- 批准号:
DE140100864 - 财政年份:2014
- 资助金额:
$ 28.89万 - 项目类别:
Discovery Early Career Researcher Award
The characterisation of the functional regions of sarcomeric alpha-actinins and to determine how the absence of alpha-actinin-3 influences human skeletal muscle function and metabolism.
肌节 α-肌动蛋白功能区域的表征,并确定 α-肌动蛋白-3 的缺失如何影响人类骨骼肌功能和代谢。
- 批准号:
nhmrc : 1038991 - 财政年份:2012
- 资助金额:
$ 28.89万 - 项目类别:
Postgraduate Scholarships
Collaborative Research: Regulation of Cellular Mechanics by Crosslinked Actin Networks - Role of Palladin and Alpha-actinin
合作研究:交联肌动蛋白网络调节细胞力学 - Palladin 和 α-肌动蛋白的作用
- 批准号:
1121365 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
Continuing Grant
Collaborative Research: Regulation of Cellular Mechanics by Crosslinked Actin Networks - Role of Palladin and Alpha-actinin
合作研究:交联肌动蛋白网络调节细胞力学 - Palladin 和 α-肌动蛋白的作用
- 批准号:
1121710 - 财政年份:2011
- 资助金额:
$ 28.89万 - 项目类别:
Continuing Grant
Elucidating the role of palladin/alpha-actinin in cell motility and invasion
阐明 Palladin/α-肌动蛋白在细胞运动和侵袭中的作用
- 批准号:
7928090 - 财政年份:2009
- 资助金额:
$ 28.89万 - 项目类别: